Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Allyl bromide | HCID 7841 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 54047026 | HCID 54047026 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 53750833 | HCID 53750833 | 88.6% |
Reaction Steps
3 g (7.7 mmol) of crude (S)-1-(5-aminomethyl-1,2,4-oxadiazol-3-yl)-8-trifluoromethyl-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one, 50 ml of methylene chloride, 14.2 ml (72 mmol) of N-ethyldiisopropylamine and 5.14 g (3.6 mmol) of allyl bromide were stirred at room temperature overnight and at 40° for 4 hours. The reaction solution was washed three times with water, dried over magnesium sulfate and evaporated. The residue was chromatographed on 390 g of silica gel while eluting with ethyl acetate. There were obtained 1.50 g (41%) of (S)-1-(5-diallylaminomethyl-1,2,4-oxadiazol-3-yl)-8-trifluoromethyl-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one, which was converted into the dihydrochloride with methanolic hydrochloric acid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-c0a8778b0509415f84dbb7521eca1b39 |
|---|
| Source note | uspto-grants-1997_09 |
|---|